Facebook
Twitter
LinkedIn
Forward
The session will begin by providing a general overview of the prevalence and epidemiology of nonalcoholic fatty liver disease.
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
Incretin medications, like semaglutide and tirzepatide, suppress appetite and delay gastric emptying, facilitating weight loss and begging the question of the need for concurrent behavior change th
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
In this session, co-presented by a primary care and an obesity-focused tertiary care provider, we will review barriers and facilitators to pediatric obesity treatment in primary and tertiary care s
|
70% of Americans have pre-obesity or the serious, chronic, and relapsing disease of obesity.
|
This lecture explores the relationship between endocrine disruptors and their potential role in obesity.
|
Neurodiversity refers to the natural variation in neurological and cognitive function present in the human population.
|
The midlife stage in women is characterized by significant changes related to aging, menopause, and lifestyle.
|
The patient with inflammatory bowel disease (IBD), either Crohn's disease or ulcerative colitis, faces specific challenges in the management of obesity.
|